Longeveron Balance Sheet Health
Financial Health criteria checks 6/6
Longeveron has a total shareholder equity of $25.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $29.9M and $4.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$22.78m |
| Equity | US$25.63m |
| Total liabilities | US$4.28m |
| Total assets | US$29.91m |
Recent financial health updates
Will Longeveron (NASDAQ:LGVN) Spend Its Cash Wisely?
Nov 17
Is Longeveron (NASDAQ:LGVN) In A Good Position To Invest In Growth?
Jul 15Recent updates
Will Longeveron (NASDAQ:LGVN) Spend Its Cash Wisely?
Nov 17Longeveron Inc.: A New Approach To Treat Alzheimer's
Oct 09Longeveron spikes after FDA’s Fast Track Designation for lead candidate
Aug 31Is Longeveron (NASDAQ:LGVN) In A Good Position To Invest In Growth?
Jul 15Longeveron rises ~20%, co to present Alzheimer's trial abstract at leading conference
Jul 07Financial Position Analysis
Short Term Liabilities: LGVN's short term assets ($23.8M) exceed its short term liabilities ($3.1M).
Long Term Liabilities: LGVN's short term assets ($23.8M) exceed its long term liabilities ($1.2M).
Debt to Equity History and Analysis
Debt Level: LGVN is debt free.
Reducing Debt: LGVN has no debt compared to 5 years ago when its debt to equity ratio was 61.4%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LGVN has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: LGVN has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 29.1% each year.